The predictive value of the interferon-γ release assay for chemotherapy responses in patients with advanced non-small-cell lung cancer

A higher pre-treatment PSIG response, obtained using the IGRA, was associated with better disease control rate and survival among patients with advanced NSCLC treated with chemotherapy.